IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Venrock Adviser, LLC

Q1 2020 Holdings

Filed 2020-05-15 | 16 holdings | $48.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Axsome Therapeutics Inc(AXSM)COM05464T104$47.7M810,00099.3%
Constellation Pharmaceuticals Inc(CNST)COM210373106$126.3K4,016,8730.3%
Relmada Therapeutics Inc(RLMD)COM75955J402$28.7K842,8140.1%
Trillium Therapeutics IncCOM NEW89620X506$27.4K6,790,0000.1%
89Bio Inc(ETNBGBP)COM282559103$24.0K952,2000.1%
Inovio Pharmaceuticals IncCOM NEW45773H201$21.6K2,900,0000.0%
10X Genomics Inc(TXG)CL A COM88025U109$18.7K300,0000.0%
Mersana Therapeutics IncCOM59045L106$15.3K2,623,9030.0%
Marinus Pharmaceuticals IncCOM56854Q101$13.2K6,502,8400.0%
Verastem IncCOM92337C104$9.8K3,720,9300.0%
Adverum Biotechnologies Inc(ADVMCHF)COM00773U108$9.7K994,3810.0%
Iveric BIO Inc(OPHTEUR)COM46583P102$8.9K2,586,5370.0%
Avadel Pharmaceuticals PLCSPONS ADR05337M104$8.4K1,057,8270.0%
Sierra Oncology IncCOM NEW82640U404$4.8K491,0170.0%
Spero Therapeutics Inc(SPRO)COM84833T103$3.8K474,0150.0%
Protagonist Therapeutics Inc(PTGX)COM74366E102$799113,1400.0%